SANOFICONR

Sanofi Consumer Healthcare India Limited

Source: NSE · Updated 4 Nov, 06:28 pm IST

Filed 28 Oct, 07:17 pm IST Q2 FY27 (Sep ’26)Standalone (no consolidated filing)₹ millions

Revenue

2,631

▲ 12.5% vs Q2 FY26

Operating profit (EBITDA, derived from filing)

1,017

▲ 19.6% vs Q2 FY26

Net profit

766

▲ 21.8% vs Q2 FY26

EPS (₹)

33.26

▲ 21.8% vs Q2 FY26

Operating margin

38.7%

+240 bps vs Q2 FY26

Net margin

29.1%

+220 bps vs Q2 FY26

Revenue up, profit up vs Q2 FY26

Revenue+12% vs Q2 FY26 · +12% vs Q1 FY27

Profit+22% vs Q2 FY26 · +11% vs Q1 FY27

View official filing ↗

Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.

Previous-quarter and year-ago figures: as originally reported in those quarters' NSE filings; filing PDF not available to confirm restatements.

Quarter comparison

Item	Q2 FY27 (Sep ’26)	Q1 FY27 (Jun ’26)	vs Q1 FY27	Q2 FY26 (Sep ’25)	vs Q2 FY26
Revenue from operations	2,631	2,357	▲ 11.6%	2,339	▲ 12.5%
Other income	44	63	▼ 30.2%	30	▲ 46.7%
Total income	2,675	2,420	▲ 10.5%	2,369	▲ 12.9%
Total expenses	1,648	1,501	▲ 9.8%	1,528	▲ 7.9%
Operating profit (EBITDA)*	1,017	893	▲ 13.9%	850	▲ 19.6%
Profit before tax	1,027	919	▲ 11.8%	841	▲ 22.1%
Tax expense	261	231	▲ 13.0%	212	▲ 23.1%
Net profit	766	688	▲ 11.3%	629	▲ 21.8%
EPS (₹)	33.26	29.87	▲ 11.3%	27.31	▲ 21.8%
Operating margin	38.7%	37.9%	+80 bps	36.3%	+240 bps
Net margin	29.1%	29.2%	−10 bps	26.9%	+220 bps

Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).

Figures in ₹ millions except EPS. Standalone figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.

All Sanofi Consumer Healthcare India results, dividends & filings ›

Other results filed 28 Oct

ORBTEXP Orbit Exports Limited›GMRAIRPORT GMR AIRPORTS LIMITED›CHOLAFIN Cholamandalam Investment and Finance Company Limited›MOSCHIP Moschip Technologies Limited›ONMOBILE OnMobile Global Limited›INFOBEAN InfoBeans Technologies Limited›DODLA Dodla Dairy Limited›BOROSCI Borosil Scientific Limited›ZENSARTECH Zensar Technologies Limited›GRPLTD GRP Limited›ADANIENT Adani Enterprises Limited›CNL Creative Newtech Limited›

Today's results ›

SANOFI CONSUMER HEALTHCARE INDIA Q2 FY27 ; NET PROFIT UP 22% AT ₹77 CR (YOY), UP 11% (QOQ)

REVENUE UP 12% AT ₹263 CR (YOY), UP 12% (QOQ)

EBITDA UP 20% AT ₹102 CR (YOY), UP 14% (QOQ)

MARGINS AT 38.7% VS 36.3% (YOY), 37.9% (QOQ)

https://resultkal.com/r/sanoficonr-2026-10-28
Source: NSE filing · not investment advice

FAQ

When did Sanofi Consumer Healthcare India announce Q2 FY27 results?

Sanofi Consumer Healthcare India filed its results on NSE on 28 Oct, 07:17 pm IST.

What does QoQ and YoY mean?

QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.

Are these Sanofi Consumer Healthcare India figures official?

They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.

Explore

Today's results Results this week Q2 FY27 results dates Dividend stocks this week Bonus issue 2026 Stock split 2026

Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.

← SANOFICONR overview